We are currently upgrading our website. Please bear with us if you are experiencing any loading issues.
The Voice of MedTech in Asia
Home » Newsletter 2024 Q2 » TRANSFORMING OURSELVES
As the healthcare landscape in our region rapidly evolves, APACMed is taking a proactive approach to enhance impact in support of our members.
With effect from 1 May 2024, our committees and working groups will strengthen their focus to leverage member expertise more effectively, leading to stronger outcomes and more innovative solutions for the industry.
APACMed Committees & Working Groups
Policy Shaping for a Conducive Business Environment.
Shaping policies that foster an environment with robust cybersecurity and data standards to optimise the utilisation of health data for innovation and improved patient outcomes.
Supporting, advocating and elevating ethics & compliance standards in our industry.
Championing value assessment and funding for medical technologies in Asia Pacific to enhance patient access.
Navigating an increasingly complex and fragmented regulatory landscape.
From a few start-ups to a MedTech innovation ecosystem.
Your unwavering support has enabled APACMed to deliver a decade of progress.
We are confident that with your continued support, these changes will allow us to be more agile and adaptable, in seizing opportunities and facing industry headwinds in the years to come.
Please feel free to reach out to the secretariat team if you have any questions.
For an overview of APACMed’s committees and working groups and their respective board sponsors and secretariat leads and secretariat support staff, click here.
APACMed provides a unifying voice for the medical devices and in-vitro diagnostics industry in Asia Pacific. Founded in 2014, APACMed strives to promote innovation and impact policy that advances healthcare access for patients.
© Asia Pacific Medical Technology Association Ltd. All rights reserved. Read Our Terms Of Use